Sanalitro backs HB4327 to audit state’s use of federal 340B drug discount program

Rep. Jennifer Sanalitro (R-48th) voted in favor of HB4327, which calls for an audit of Illinois' participation in the federal 340B Drug Discount Program, during the 104th General Assembly on May 31, 2026, according to the Illinois House. The measure passed with a 106-8 majority.

The bill's official text refers to the action as: "AUDITOR GENERAL-340B AUDIT."

The following summary provides an interpretation of the bill text to clarify its main provisions.

The bill instructs the Illinois auditor general to launch a thorough audit, after the law’s effective date, of how 340B covered entities in Illinois engage with the federal 340B Drug Discount Program. The audit must review profits from 340B drugs, payments related to third-party administrators, disbursements to pharmacy benefit managers and contract pharmacies, drug ownership structures at contract pharmacy locations, typical markups on discounted drugs, and the frequency with which qualifying patients receive discounts at the point of sale. A comprehensive report with findings and recommendations will be submitted to the General Assembly by the auditor general.

The official legislative record for HB4327 noted: 'Senate Committee Amendment No. 1 House Concurs.'

Sanalitro, a member of the Republican Party, was elected to represent Illinois’ 48th House District in 2023, succeeding former state representative Terra Costa Howard.

Illinois bills proceed through a multi-step legislative process that begins with introduction in either chamber, followed by committee review, debates, and votes in both the House and Senate, after which the legislation is sent to the governor for approval or veto. The General Assembly operates on a biennial cycle, and while many bills are introduced each session, only a smaller portion complete the full legislative process to become law.